Key facts
- Delve (Business/Productivity Software)’s last known valuation is $300.0M (Jul 2025).
- It has raised $35.8M; the latest was Early Stage VC ($32.0M) in Jul 2025.
- Notable investors include Y Combinator, General Catalyst, Soma Capital, Insight Partners (New York), E14 Fund — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Delve (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Delve (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Delve (Business/Productivity Software)
Developer of a tracking platform designed to track the journey of HIPAA compliance. The company's platform offers features such as the deployment of work, paperwork automation, and monitoring compliance to automate the tedious work of gathering evidence and maintaining continuous conformity, enabling fast-growing startups and enterprises to streamline documentation by providing pipelines for infrastructure updates straight from git push.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 17
- Website
- delve.co/
- Ownership
- Privately Held (backing)
Delve (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Delve (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Delve (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.